MedCap AB Achieves 20% EBITA Growth and Expands with XGX Pharma Acquisition
MedCap AB reports 20% growth in EBITA and completes strategic acquisition of XGX Pharma, solidifying its position as a leader in the Life Sciences sector.
3 minutes to read
Medcap AB Bolsters Specialty Pharma Portfolio with Acquisition of XGX Pharma
Medcap AB, a Swedish investment company, has acquired Danish pharmaceutical company XGX Pharma for 135 million Danish kronor, aiming to strengthen its position in the Specialty Pharma business area.
2 minutes to read
Medcap AB Stock Faces Scrutiny After Recent Price Drop and Valuation Concerns
Medcap AB’s stock price has declined, sparking scrutiny, with investors and analysts closely monitoring the company’s developments due to high valuation metrics and recent price drops.
2 minutes to read